Rana P Singh Selected Research

Rana P Singh Research Topics

Disease

94	Neoplasms (Cancer) 01/2024 - 03/2002
32	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 06/2002
29	Carcinoma (Carcinomatosis) 01/2023 - 06/2002
22	Carcinogenesis 01/2024 - 08/2002
16	Body Weight (Weight, Body) 01/2024 - 01/2004
11	Breast Neoplasms (Breast Cancer) 11/2023 - 05/2004
9	Adenocarcinoma 01/2020 - 11/2003
9	Skin Neoplasms (Skin Cancer) 01/2018 - 03/2002
9	Colorectal Neoplasms (Colorectal Cancer) 05/2014 - 10/2006
8	Neoplasm Metastasis (Metastasis) 01/2024 - 06/2003
8	Lung Neoplasms (Lung Cancer) 12/2022 - 06/2006
7	Hypoxia (Hypoxemia) 09/2015 - 09/2006
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2022 - 05/2003
4	Papilloma (Papillomatosis) 01/2008 - 03/2002
3	Stomach Neoplasms (Stomach Cancer) 01/2020 - 01/2017
3	Inflammation (Inflammations) 08/2019 - 09/2005
3	Urinary Bladder Neoplasms (Bladder Cancer) 01/2008 - 12/2003
3	Sunburn 08/2005 - 08/2004
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2005 - 03/2002
2	Atherosclerosis 01/2024 - 01/2005
2	Head and Neck Neoplasms (Head and Neck Cancer) 01/2024 - 01/2021
2	Glioma (Gliomas) 01/2019 - 09/2003
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 09/2018 - 06/2018

Drug/Important Bio-Agent (IBA)

52	Silybin (Lagosa)IBA 09/2022 - 03/2002
17	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2013 - 09/2003
16	Proteins (Proteins, Gene)FDA Link 01/2024 - 09/2003
10	PhytochemicalsIBA 06/2022 - 05/2002
9	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2003
9	Proliferating Cell Nuclear Antigen (PCNA)IBA 02/2014 - 03/2002
9	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 10/2012 - 06/2006
9	Grape Seed ExtractIBA 07/2011 - 11/2002
8	FlavonoidsIBA 08/2019 - 06/2002
8	Phytic Acid (Inositol Hexaphosphate)IBA 02/2009 - 03/2003
8	SilymarinIBA 12/2008 - 03/2002
7	AndrogensIBA 01/2023 - 11/2002
7	fisetinIBA 12/2022 - 02/2012
6	EnzymesIBA 08/2023 - 01/2005
6	Cyclin-Dependent Kinases (cdk Proteins)IBA 08/2019 - 11/2003
6	NF-kappa B (NF-kB)IBA 07/2010 - 09/2003
6	CarcinogensIBA 12/2007 - 08/2002
5	Antineoplastic Agents (Antineoplastics)IBA 01/2024 - 02/2005
5	AntioxidantsIBA 03/2018 - 06/2002
5	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017 - 11/2002
5	CyclinsIBA 01/2017 - 03/2003
5	flavanoneIBA 01/2015 - 12/2003
5	beta CateninIBA 07/2010 - 12/2009
5	Transcription Factors (Transcription Factor)IBA 07/2008 - 09/2004
5	CaspasesIBA 11/2006 - 11/2002
5	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 05/2005 - 03/2002
4	BerberineIBA 01/2024 - 02/2014
4	acacetinIBA 01/2023 - 04/2005
4	Drinking WaterIBA 01/2018 - 12/2007
4	CytokinesIBA 10/2012 - 07/2008
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2012 - 08/2002
4	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 10/2012 - 06/2006
4	Cyclin D1IBA 01/2010 - 06/2006
4	Insulin-Like Growth Factor Binding Protein 3IBA 12/2007 - 09/2003
3	AlkaloidsIBA 01/2024 - 02/2014
3	MicroRNAs (MicroRNA)IBA 01/2024 - 01/2019
3	diallyl trisulfideIBA 01/2024 - 06/2021
3	Cadherins (E-Cadherin)IBA 08/2023 - 12/2008
3	VimentinIBA 08/2023 - 12/2008
3	DNA (Deoxyribonucleic Acid)IBA 11/2020 - 01/2005
3	ArsenicIBA 01/2018 - 06/2011
3	Cytochromes c (Cytochrome c)IBA 01/2016 - 11/2002
3	Caspase 3 (Caspase-3)IBA 02/2014 - 09/2004
3	AzoxymethaneIBA 09/2010 - 10/2008
3	Matrix Metalloproteinases (MMPs)IBA 12/2008 - 09/2006
3	SurvivinIBA 01/2008 - 12/2003
3	Phosphotransferases (Kinase)IBA 11/2006 - 09/2004
3	Insulin-Like PeptidesIBA 02/2004 - 06/2002
3	milk-thistle extractIBA 12/2003 - 06/2002
2	oxidized low density lipoproteinIBA 01/2024 - 08/2019
2	LigandsIBA 11/2023 - 06/2006
2	Conditioned Culture MediaIBA 11/2023 - 10/2013
2	benzyl isothiocyanateIBA 11/2023 - 01/2016
2	XenobioticsIBA 08/2023 - 09/2005
2	Trypan Blue FDA Link 08/2023 - 05/2003
2	decursinIBA 01/2023 - 02/2005
2	coumarinIBA 01/2023 - 01/2009
2	Cyclin-Dependent Kinase Inhibitor p27IBA 01/2023 - 02/2009
2	Cyclin-Dependent Kinase 4IBA 01/2023 - 09/2004
2	ErbB Receptors (EGF Receptor)IBA 09/2022 - 09/2003
2	RNA (Ribonucleic Acid)IBA 06/2022 - 06/2021
2	Messenger RNA (mRNA)IBA 05/2021 - 12/2003
2	Insulin (Novolin)FDA Link 01/2021 - 09/2010
2	usnic acidIBA 01/2020 - 01/2013
2	ResveratrolIBA 01/2020 - 11/2005
2	ZincIBA 01/2019 - 01/2005
2	Gallic AcidIBA 03/2018 - 07/2006
2	AnthracyclinesIBA 01/2017 - 12/2004
2	matrigelIBA 10/2013 - 02/2004
2	Tyrosine (L-Tyrosine)FDA Link 10/2013 - 11/2005
2	Urethane (Ethyl Carbamate)IBA 02/2011 - 06/2006
2	NestinIBA 02/2011 - 01/2009
2	Glycogen Synthase (Synthase I)IBA 09/2010 - 12/2009

Therapy/Procedure

20	Chemoprevention 01/2016 - 01/2004
13	Therapeutics 01/2024 - 08/2002
3	Drug Therapy (Chemotherapy) 01/2016 - 05/2004
3	Radiotherapy 12/2015 - 11/2011